Last updated

Terumo Corporation
Type Public (K.K)
TYO: 4543
Nikkei 225 Component
Industry Medical equipment
FoundedSeptember 17, 1921
Headquarters44-1, 2-chome, Hatagaya, Shibuya-ku, Tokyo 151-0072, Japan
Key people
Takayoshi Mimura, (Chairman)
Shinjiro Sato, (President)
RevenueIncrease2.svg $ 4.27 billion (FY 2012) (¥ 402.294 billion) (FY 2012)
Increase2.svg $ 500.01 million (FY 2012) (¥ 47.01 billion) (FY 2012)
Number of employees
19,261 (consolidated) (as of September 30, 2013)
Subsidiaries Terumo Cardiovascular Systems, Corp.
Vascutek Ltd.
Microvention Inc.
Website Official website
Footnotes /references
[1] [2]

Terumo Corporation (テルモ株式会社, Terumo Kabushiki-gaisha) was founded in 1921 as Red Line Thermometer Corporation by a group of medical scientists led by Dr. Kitasato Shibasaburō to produce medical thermometers in Japan.


The company's first product was "Jintan Taionkei", the first Japanese-made thermometer available for sale, and it has since expanded into a medical devices manufacturer, producing medical disposables, cardiovascular systems and diabetes care products.[ not verified in body ]

In 1971, Terumo opened its first overseas office in the United States. Since then, the company has established subsidiaries in Europe (1971), South America, China, India, Philippines, Vietnam, Thailand and Australia. The company later expanded its product range to include coronary stents and catheters, and acquired, among others, the cardiovascular specialty companies Vascutek and Microvention in 2002 and 2006 respectively.

Business segments and products

A Terumo thermometer terumoTi Wen Ji 001.JPG
A Terumo thermometer

As of 2014 Terumo Corporation was organized into three business business segments: [3]

Terumo Penpol, the company's subsidiary in Trivandrum, India is the largest manufacturer of blood bags in India and supplies it to over 82 countries. [4]

A medical device facility called Terumo BCT is located in Denver suburb of Lakewood, Colorado, and as of 2018, has been open and operating for over 20 years. [5] A 2018 investigation into the release of ethylene oxide—a sterilizing agent for the blood diagnostic and treatment devices—into the atmosphere showed no increased cancer risk for those in the neighborhood, and the EPA will continue to allow up to 4,500 kg (10,000 lb) of ethylene oxide to be released annually. However, Terumo said they release only 1,100 kg (2,500 lb) per year and are working to reduce that amount. [5]


In July 1999 Terumo acquired the cardiovascular division of 3M Company, and established Terumo Cardiovascular Systems Corp. in the USA. [6]

In 2001 the company made two more acquisitions: it acquired the home oxygen division of Sumitomo Bakelite Co., Ltd., and establish Terumo Medical Care K.K., and Ikiken Co., Ltd. of Japan.[ citation needed ]

In 2002 the company enters into the vascular prostheses business by acquiring UK-based Vascutek Ltd.[ citation needed ]

Four years later, in 2006 the company ventured into a new field (endovascular coils for the treatment of cerebral aneurysms) by buying American company MicroVention Inc.[ citation needed ]

The tissue heart valve division of Kohler Chemine GmbH was acquired in March 2007 and expanded Terumo's operations related to vascular prostheses.[ citation needed ]

A year later the Japanese company Clinical Supply Co., Ltd. became a Terumo subsidiary and enhanced Terumo's interventional systems business in the field of radiotherapy.[ citation needed ]

In March 2011, the company bought U.S. medical device company CaridianBCT for around $2.6 billion. It was the largest acquisition[ according to whom? ] by a Japanese medical equipment maker at the time. [7]

The same year Harvest Technologies Corporation—point-of-care cell therapy—and Onset Medical Corp.—sheath technology designed for multiple, minimally-invasive clinical applications—was acquired. [8]

Related Research Articles


Angioplasty, also known as balloon angioplasty and percutaneous transluminal angioplasty (PTA), is a minimally invasive endovascular procedure used to widen narrowed or obstructed arteries or veins, typically to treat arterial atherosclerosis. A deflated balloon attached to a catheter is passed over a guide-wire into the narrowed vessel and then inflated to a fixed size. The balloon forces expansion of the blood vessel and the surrounding muscular wall, allowing an improved blood flow. A stent may be inserted at the time of ballooning to ensure the vessel remains open, and the balloon is then deflated and withdrawn. Angioplasty has come to include all manner of vascular interventions that are typically performed percutaneously.

Interventional radiology

Interventional radiology (IR) is a medical subspecialty that performs various minimally-invasive procedures using medical imaging guidance, such as x-ray fluoroscopy, computed tomography, magnetic resonance imaging, or ultrasound. IR performs both diagnostic and therapeutic procedures through very small incisions or body orifices. Diagnostic IR procedures are those intended to help make a diagnosis or guide further medical treatment, and include image-guided biopsy of a tumor or injection of an imaging contrast agent into a hollow structure, such as a blood vessel or a duct. By contrast, therapeutic IR procedures provide direct treatment—they include catheter-based medicine delivery, medical device placement, and angioplasty of narrowed structures.

Cardiac catheterization

Cardiac catheterization is the insertion of a catheter into a chamber or vessel of the heart. This is done both for diagnostic and interventional purposes. A common example of cardiac catheterization is coronary catheterization that involves catheterization of the coronary arteries for coronary artery disease and myocardial infarctions. Catheterization is most often performed in special laboratories with fluoroscopy and highly maneuverable tables. These "cath labs" are often equipped with cabinets of catheters, stents, balloons, etc. of various sizes to increase efficiency. Monitors show the fluoroscopy imaging, electrocardiogram (ECG), pressure waves, and more.

Boston Scientific U.S.-based medical device company

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Guidant Corporation, part of Boston Scientific and Abbott Labs, designs and manufactures artificial cardiac pacemakers, implantable cardioverter-defibrillators, stents, and other cardiovascular medical products. Their company headquarters is located in Indianapolis, Indiana. Their main competitors are Medtronic, St. Jude Medical, and Johnson and Johnson.

St. Jude Medical, Inc. was an American global medical device company headquartered in Little Canada, Minnesota, U.S., a suburb of Saint Paul. The company had more than 20 principal operations and manufacturing facilities worldwide with products sold in more than 100 countries. Its major markets include the United States, Europe, Latin America and Asia-Pacific. The company was named after Jude the Apostle, the patron saint of lost causes.

Cordis (medical)

Cordis develops and manufactures medical devices for diagnostics and interventional procedures to treat patients suffering from coronary and peripheral vascular diseases.

Endovascular aneurysm repair Surgery used to treat abdominal aortic aneurysm

Endovascular aneurysm repair (EVAR), is a type of minimally-invasive endovascular surgery used to treat pathology of the aorta, most commonly an abdominal aortic aneurysm (AAA). When used to treat thoracic aortic disease, the procedure is then specifically termed TEVAR for "thoracic endovascular aortic/aneurysm repair." The procedure involves the placement of an expandable stent graft within the aorta to treat aortic disease without operating directly on the aorta. In 2003, EVAR surpassed open aortic surgery as the most common technique for repair of AAA, and in 2010, EVAR accounted for 78% of all intact AAA repair in the United States.

Dr. Thomas J. "Tom" Fogarty is an American surgeon and medical device inventor. He is best known for the invention of the embolectomy catheter, which revolutionised the treatment of blood clots (embolus).

The Sorin Group was a medical products group based in Italy, with significant operations in France, the United States, and Japan, specializing in cardiac devices. Its product lines include replacement heart valves, oxygenators, perfusion tubing sets, cardiothoracic surgery accessories, data monitoring, heart-lung machines, autotransfusion systems, and cannulae, and a line of blood management products.

C. R. Bard

C. R. Bard, Inc., now branded as Bard, headquartered in Murray Hill, New Jersey, USA, was a developer, manufacturer, and marketer of medical technologies in the fields of vascular, urology, oncology, and surgical specialties before its acquisition by BD.

Thoratec Corporation is a United States-based company that develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart-failure patients worldwide. It is a global leader in mechanical circulatory support devices, particularly in ventricular assist devices (VADs).

Biotronik is a privately held multinational biomedical technology company headquartered in Berlin, Germany.

Vascular closure devices (VCDs) are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization.

The Mynx Vascular Closure Device is an extravascular vascular closure device (VCD) whose deployment system is designed to minimize the discomfort commonly associated with closing the small hole in the artery following catheterization procedure. The device is manufactured by AccessClosure, Inc., a medical device company located in Mountain View, California.

ICU Medical, Inc. is a San Clemente, California-based company with global operations that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications.

Terumo Penpol Limited (TPL) is a subsidiary of Terumo Corp., Japan, and is India's largest blood bag manufacturer. It is also the largest producers of blood bags in Asia, outside Japan.

A hybrid cardiac surgical procedure in a narrow sense is defined as a procedure that combines a conventional surgical part with an interventional part, using some sort of catheter-based procedure guided by fluoroscopy imaging in a hybrid OR without interruption. A wider definition includes a clinically connected succession of a catheter intervention and a surgical procedure with a time gap.

MicroPort is a global medical device developer and manufacturer that is headquartered in Shanghai, China. It designs and produces products for a range of medical fields including cardiology, interventional radiology, orthopedics, electrophysiology, and surgical management. MicroPort is considered to be among the top 100 medical device companies in 2018 and was selected to be the 2017 China Innovative Medical Device Company.

Venkatesh G. Ramaiah, MD FACS is a vascular surgeon and researcher. His areas of work include innovations in the treatment of abdominal aortic aneurysms and peripheral arterial disease. Formerly a director of the Arizona Heart Hospital, he currently serves as Chief of Complex Vascular Services of the HonorHealth hospital system based in Scottsdale, Arizona. Dr. Ramaiah is also a co-founder of Pulse Cardiovascular Institute, an ambulatory surgical center in Scottsdale.


  1. "Terumo Corporate Profile". Archived from the original on March 1, 2017. Retrieved March 17, 2014.
  2. "Terumo Financial Statement". Archived from the original on May 14, 2017. Retrieved March 17, 2014.
  3. "Terumo Products". Archived from the original on December 17, 2013. Retrieved March 17, 2014.
  4. Kurian, Vinson (31 October 2010). "Blood bags co Terumo Penpol turns 25". The Hindu. Archived from the original on 9 October 2012. Retrieved July 24, 2011.
  5. 1 2 Hernandez, Lance (18 August 2018). "Colorado to sample air near Lakewood plant after EPA identifies potential elevated cancer risk. Assessment shows normal cancer rates". 7 News . Archived from the original on 24 September 2019. Retrieved 24 September 2019.
  6. "Terumo - About Us". Archived from the original on 29 July 2016. Retrieved 1 August 2016.
  7. Mariko Katsumura (March 7, 2011). "Terumo to buy U.S. medical device firm for $2.6 billion". Reuters. Archived from the original on September 24, 2015. Retrieved March 17, 2014.
  8. "Terumo History". Archived from the original on March 1, 2017. Retrieved March 17, 2014.